Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 20.05.2021.

Therapy
Accounting analyst
Treaty of Lisbon
Monocyte
Effectiveness
Good clinical practice

Healthcare

@Biotechnology shared
On May 19, 2021
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant https://t.co/l6v5Xv40Gj https://t.co/JjL3B1SWIn
Open
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant

Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant

Thermo Fisher and the University of California partnered with the development and manufacturing of cell-based therapies with the construction of its 44,000 sq. ft. manufacturing facility.

@JNJInnovation shared
On May 19, 2021
Using state-of-the-art data analytics could allow us to create breakthroughs in #PrecisionMedicine for areas with high unmet medical need. We’ve collaborated with @Mestagtx to identify potential novel therapeutic targets in inflammatory disease. Read more: https://t.co/6iPCew4hJz https://t.co/mEbbaNKUGx
Open
Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Cambridge, UK, 18 May 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced a target discovery, option and …

@GalapagosGlobal shared
On May 18, 2021
Press Release | Galapagos announces first patient enrolled in the FILOSOPHY Phase 4 European real-world outcomes study. Read the press release here: https://t.co/bwBAtJJhsy https://t.co/1CMNhERjkP
Open
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting

Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting

Study uses mobile device technology to support capture of patient-reported outcomes during early and ongoing use of study treatment amongst patients with...

@EUScienceInnov shared
On May 20, 2021
We’re excited to open registrations for #RiDaysEU next week!🧪🧬 Keep your eyes peeled, and in the meantime you can: ✍️Subscribe for updates: https://t.co/BcJQZmwkfO 📝Check the programme: https://t.co/zHN8993RYh 🔬Explore last year’s event: https://t.co/2rgahADl3Q https://t.co/rXrxqoOWig
Open
European Research and Innovation days 2020

European Research and Innovation days 2020

The programme and video recordings of the 2020 EU Research and Innovation days

@SWLifeSciences shared
On May 14, 2021
Analyst: Biotech Expecting a 'Catalyst-Rich' Second Half of the Year: https://t.co/DHzHnt3gLc An H.C. Wainwright & Co. report discusses Gritstone Bio's recent earnings & significant corporate events. $GRTS #biotech #stocks Gritstone bio @gritstonebio https://t.co/c83i0plJzH
Open
Analyst: Biotech Expecting a 'Catalyst-Rich' Second Half of the Year Research Report

Analyst: Biotech Expecting a 'Catalyst-Rich' Second Half of the Year Research Report

An H.C. Wainwright & Co. report discusses Gritstone Bio's recent earnings and significant corporate events as the firm plans to release data on cancer and COVID-19 vaccines later this year.